| Subject: | FDA Issues Final Rule Requiring Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 28 Apr 2009 - 12:00 pm |
| The Food and Drug Administration (FDA) has issued a Final Rule that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks, such as internal bleeding and liver damage, associated with the use of these popular drugs. Products covered by this FDA action include acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs). The revised labeling applies to all OTC pain relievers and fever... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
